These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 548211)

  • 1. Effect of moxestrol on haloperidol-induced changes in striatal acetylcholine levels and dopamine turn-over.
    Euvrard C; Labrie F; Boissier JR
    Commun Psychopharmacol; 1979; 3(5):329-34. PubMed ID: 548211
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidopaminergic effect of estrogens at the striatal level.
    Euvrard C; Oberlander C; Boissier JR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):179-85. PubMed ID: 7391967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of estrogen on changes in the activity of striatal cholinergic neurons induced by DA drugs.
    Euvrard C; Labrie F; Boissier JR
    Brain Res; 1979 Jun; 169(1):215-20. PubMed ID: 455094
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of estrogens and the dopaminergic system.
    Boissier JR; Euvrard C; Labrie F
    Acta Physiol Pharmacol Bulg; 1982; 8(1-2):50-7. PubMed ID: 7124419
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term effects of haloperidol, Clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics.
    Ladinsky H; Consolo S; Samanin R; Algeri S; Ponzio F
    Adv Biochem Psychopharmacol; 1980; 24():259-65. PubMed ID: 7405665
    [No Abstract]   [Full Text] [Related]  

  • 6. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y; Fage D; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptors and cholinergic neurons in the rat neostriatum.
    Guyenet PG; Javoy F; Agid Y; Beaujouan JC; Glowinski J
    Adv Neurol; 1975; 9():43-51. PubMed ID: 238376
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of chronic haloperidol treatment on stimulated synaptic overflow of dopamine in the rat striatum.
    Wiedemann DJ; Garris PA; Near JA; Wightman RM
    J Pharmacol Exp Ther; 1992 May; 261(2):574-9. PubMed ID: 1533666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
    Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
    J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of striatal enkephalinergic neurons by antipsychotic drugs.
    Hong JS; Yoshikawa K; Kanamatsu T; Sabol SL
    Fed Proc; 1985 Jun; 44(9):2535-9. PubMed ID: 3838946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic dopamine receptors in striatal nerve endings: absence of haloperidol-induced supersensitivity.
    Raiteri M; Cerrito F; Casazza G; Levi G
    Adv Biochem Psychopharmacol; 1980; 24():37-43. PubMed ID: 7405669
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitive periods for the effect of haloperidol on development of striatal dopamine receptors.
    Rosengarten H; Friedman E; Friedhoff AJ
    Birth Defects Orig Artic Ser; 1983; 19(4):511-3. PubMed ID: 6871420
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
    Schweitzer JW; Schwartz R; Friedhoff AJ
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidopaminergic properties of yohimbine.
    Scatton B; Zivkovic B; Dedek J
    J Pharmacol Exp Ther; 1980 Nov; 215(2):494-9. PubMed ID: 7192314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
    Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of the effects of haloperidol on dopamine turnover in the striatum, olfactory tubercule and median eminence.
    Gudelsky GA; Moore KE
    J Pharmacol Exp Ther; 1977 Jul; 202(1):149-56. PubMed ID: 874811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypophysectomy prevents the striatal dopamine receptor supersensitivity produced by chronic haloperidol treatment.
    Hruska RE; Ludmer LM; Silbergeld EK
    Eur J Pharmacol; 1980 Aug; 65(4):455-6. PubMed ID: 7408951
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypophysectomy may non-selectively alter pharmacokinetic parameters to enhance the ability of haloperidol to increase striatal dopamine receptor density in the rat.
    Simpson MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1986 Oct; 35(20):3501-6. PubMed ID: 3768037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    Compton DR; Johnson KM
    J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.